New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park
TORONTO & SAN FRANCISCO, February 14, 2024 Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, biologics and cell therapies.
Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development Acceleration with Endpoints for ASCO 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.